Human immunodeficiency virus/acquired immunodeficiency syndrome prevalence, incidence, and mortality in China, 1990 to 2017: a secondary analysis of the Global Burden of Disease Study 2017 data

Abstract. Background:. Despite almost two decades of well-funded and comprehensive response efforts by the Chinese Government, human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) remains a major problem in China. Yet, few studies have recently examined long-term trends in HIV/...

Full description

Bibliographic Details
Main Authors: Xue-Jiao Liu, Jennifer M. McGoogan, Zun-You Wu, Peng Lyu
Format: Article
Language:English
Published: Wolters Kluwer 2021-05-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000001447
id doaj-a386bbae5b3043c38926dc7b336a746e
record_format Article
spelling doaj-a386bbae5b3043c38926dc7b336a746e2021-05-25T02:14:41ZengWolters KluwerChinese Medical Journal0366-69992542-56412021-05-01134101175118010.1097/CM9.0000000000001447202105200-00007Human immunodeficiency virus/acquired immunodeficiency syndrome prevalence, incidence, and mortality in China, 1990 to 2017: a secondary analysis of the Global Burden of Disease Study 2017 dataXue-Jiao LiuJennifer M. McGooganZun-You WuPeng LyuAbstract. Background:. Despite almost two decades of well-funded and comprehensive response efforts by the Chinese Government, human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) remains a major problem in China. Yet, few studies have recently examined long-term trends in HIV/AIDS prevalence, incidence, and mortality at the national level. This study aimed to determine the prevalence, incidence, and mortality trends for HIV/AIDS over the past 28 years in China. Methods:. We conducted a descriptive, epidemiological, secondary analysis of the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 data. To evaluate trends in prevalence, incidence, and mortality over the study period from 1990 to 2017, we calculated values for annual percentage change (APC) and corresponding 95% confidence intervals (CIs) using joinpoint regression analysis. Results:. A significant increase in HIV/AIDS prevalence was observed for 1990 to 2009 (APC: 10.7; 95% CI: 10.4, 11.0; P < 0.001), and then remained stable for 2009 to 2017 (APC: 0.7; 95% CI: −0.3, 1.7; P = 0.1). A significant increase in HIV incidence was also observed for 1990 to 2005 (APC: 13.0; 95% CI: 12.6, 13.4; P < 0.001), and then a significant decrease was detected for 2005 to 2017 (APC: −6.5; 95% CI: −7.0, −6.1; P < 0.001). A significant increase in AIDS-related mortality rate was detected for 1990 to 2004 (APC: 10.3; 95% CI: 9.3, 11.3; P < 0.001), followed by a period of stability for 2004 to 2013 (APC: 1.3; 95% CI: −0.7, 3.3; P = 0.2), and then another significant increase for 2013 to 2017 (APC: 15.3; 95% CI: 8.7, 22.2; P < 0.001). Conclusions:. Although prevalence has stabilized and incidence has declined, AIDS-related mortality has risen sharply in recent years. These findings suggest more must be done to bring people into treatment earlier, retain them in treatment more effectively, actively seek to reenter them in treatment if they dropout, and improve the quality of treatment and care regimens.http://journals.lww.com/10.1097/CM9.0000000000001447
collection DOAJ
language English
format Article
sources DOAJ
author Xue-Jiao Liu
Jennifer M. McGoogan
Zun-You Wu
Peng Lyu
spellingShingle Xue-Jiao Liu
Jennifer M. McGoogan
Zun-You Wu
Peng Lyu
Human immunodeficiency virus/acquired immunodeficiency syndrome prevalence, incidence, and mortality in China, 1990 to 2017: a secondary analysis of the Global Burden of Disease Study 2017 data
Chinese Medical Journal
author_facet Xue-Jiao Liu
Jennifer M. McGoogan
Zun-You Wu
Peng Lyu
author_sort Xue-Jiao Liu
title Human immunodeficiency virus/acquired immunodeficiency syndrome prevalence, incidence, and mortality in China, 1990 to 2017: a secondary analysis of the Global Burden of Disease Study 2017 data
title_short Human immunodeficiency virus/acquired immunodeficiency syndrome prevalence, incidence, and mortality in China, 1990 to 2017: a secondary analysis of the Global Burden of Disease Study 2017 data
title_full Human immunodeficiency virus/acquired immunodeficiency syndrome prevalence, incidence, and mortality in China, 1990 to 2017: a secondary analysis of the Global Burden of Disease Study 2017 data
title_fullStr Human immunodeficiency virus/acquired immunodeficiency syndrome prevalence, incidence, and mortality in China, 1990 to 2017: a secondary analysis of the Global Burden of Disease Study 2017 data
title_full_unstemmed Human immunodeficiency virus/acquired immunodeficiency syndrome prevalence, incidence, and mortality in China, 1990 to 2017: a secondary analysis of the Global Burden of Disease Study 2017 data
title_sort human immunodeficiency virus/acquired immunodeficiency syndrome prevalence, incidence, and mortality in china, 1990 to 2017: a secondary analysis of the global burden of disease study 2017 data
publisher Wolters Kluwer
series Chinese Medical Journal
issn 0366-6999
2542-5641
publishDate 2021-05-01
description Abstract. Background:. Despite almost two decades of well-funded and comprehensive response efforts by the Chinese Government, human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) remains a major problem in China. Yet, few studies have recently examined long-term trends in HIV/AIDS prevalence, incidence, and mortality at the national level. This study aimed to determine the prevalence, incidence, and mortality trends for HIV/AIDS over the past 28 years in China. Methods:. We conducted a descriptive, epidemiological, secondary analysis of the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 data. To evaluate trends in prevalence, incidence, and mortality over the study period from 1990 to 2017, we calculated values for annual percentage change (APC) and corresponding 95% confidence intervals (CIs) using joinpoint regression analysis. Results:. A significant increase in HIV/AIDS prevalence was observed for 1990 to 2009 (APC: 10.7; 95% CI: 10.4, 11.0; P < 0.001), and then remained stable for 2009 to 2017 (APC: 0.7; 95% CI: −0.3, 1.7; P = 0.1). A significant increase in HIV incidence was also observed for 1990 to 2005 (APC: 13.0; 95% CI: 12.6, 13.4; P < 0.001), and then a significant decrease was detected for 2005 to 2017 (APC: −6.5; 95% CI: −7.0, −6.1; P < 0.001). A significant increase in AIDS-related mortality rate was detected for 1990 to 2004 (APC: 10.3; 95% CI: 9.3, 11.3; P < 0.001), followed by a period of stability for 2004 to 2013 (APC: 1.3; 95% CI: −0.7, 3.3; P = 0.2), and then another significant increase for 2013 to 2017 (APC: 15.3; 95% CI: 8.7, 22.2; P < 0.001). Conclusions:. Although prevalence has stabilized and incidence has declined, AIDS-related mortality has risen sharply in recent years. These findings suggest more must be done to bring people into treatment earlier, retain them in treatment more effectively, actively seek to reenter them in treatment if they dropout, and improve the quality of treatment and care regimens.
url http://journals.lww.com/10.1097/CM9.0000000000001447
work_keys_str_mv AT xuejiaoliu humanimmunodeficiencyvirusacquiredimmunodeficiencysyndromeprevalenceincidenceandmortalityinchina1990to2017asecondaryanalysisoftheglobalburdenofdiseasestudy2017data
AT jennifermmcgoogan humanimmunodeficiencyvirusacquiredimmunodeficiencysyndromeprevalenceincidenceandmortalityinchina1990to2017asecondaryanalysisoftheglobalburdenofdiseasestudy2017data
AT zunyouwu humanimmunodeficiencyvirusacquiredimmunodeficiencysyndromeprevalenceincidenceandmortalityinchina1990to2017asecondaryanalysisoftheglobalburdenofdiseasestudy2017data
AT penglyu humanimmunodeficiencyvirusacquiredimmunodeficiencysyndromeprevalenceincidenceandmortalityinchina1990to2017asecondaryanalysisoftheglobalburdenofdiseasestudy2017data
_version_ 1721428134007406592